Cardiac amyloidosis laboratory findings
|
Cardiac amyloidosis Microchapters |
|
Diagnosis |
|---|
|
Treatment |
|
Case Studies |
|
Cardiac amyloidosis laboratory findings On the Web |
|
American Roentgen Ray Society Images of Cardiac amyloidosis laboratory findings |
|
Risk calculators and risk factors for Cardiac amyloidosis laboratory findings |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Raviteja Guddeti, M.B.B.S. [2]; Aarti Narayan, M.B.B.S [3]; Lakshmi Gopalakrishnan, M.B.B.S. [4]
Overview
There is no specific diagnostic blood test, radiograph, or scan that can be used to diagnose amyloidosis; hence, awareness of the disease is necessary to identify patients with amyloidosis.[1]
Laboratory Findings
The following are the laboratory tests included in the management of cardiac amyloidosis:
- Complete blood count: Normocytic normochromic anemia may be present
- Serum troponins
- Atrial natriuretic peptide: Elevated in heart failure
- Brain natriuretic peptide: Elevated in heart failure
- Serum transthyretin
- Urinalysis for proteinuria
- Serum and urine electrophoresis
- Serum and urine immunofixation
- Serum electrolytes
References
- ↑ Hawkins PN (1997). "The diagnosis, natural history and treatment of amyloidosis. The Goulstonian Lecture 1995". Journal of the Royal College of Physicians of London. 31 (5): 552–60. PMID 9429195.
|access-date=requires|url=(help)